244 related articles for article (PubMed ID: 22863010)
1. Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL.
Wen Q; Goldenson B; Silver SJ; Schenone M; Dancik V; Huang Z; Wang LZ; Lewis TA; An WF; Li X; Bray MA; Thiollier C; Diebold L; Gilles L; Vokes MS; Moore CB; Bliss-Moreau M; Verplank L; Tolliday NJ; Mishra R; Vemula S; Shi J; Wei L; Kapur R; Lopez CK; Gerby B; Ballerini P; Pflumio F; Gilliland DG; Goldberg L; Birger Y; Izraeli S; Gamis AS; Smith FO; Woods WG; Taub J; Scherer CA; Bradner JE; Goh BC; Mercher T; Carpenter AE; Gould RJ; Clemons PA; Carr SA; Root DE; Schreiber SL; Stern AM; Crispino JD
Cell; 2012 Aug; 150(3):575-89. PubMed ID: 22863010
[TBL] [Abstract][Full Text] [Related]
2. Fasudil promotes polyploidization of megakaryoblasts in an acute megakaryocyte leukemia model.
He B; Wang C; Niu J; Wang F; Zhang Y; Gao Y; Yang Q
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3101-3110. PubMed ID: 37162543
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathways: induction of polyploidy as a novel differentiation therapy for leukemia.
Krause DS; Crispino JD
Clin Cancer Res; 2013 Nov; 19(22):6084-8. PubMed ID: 23963861
[TBL] [Abstract][Full Text] [Related]
4. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.
Thiollier C; Lopez CK; Gerby B; Ignacimouttou C; Poglio S; Duffourd Y; Guégan J; Rivera-Munoz P; Bluteau O; Mabialah V; Diop M; Wen Q; Petit A; Bauchet AL; Reinhardt D; Bornhauser B; Gautheret D; Lecluse Y; Landman-Parker J; Radford I; Vainchenker W; Dastugue N; de Botton S; Dessen P; Bourquin JP; Crispino JD; Ballerini P; Bernard OA; Pflumio F; Mercher T
J Exp Med; 2012 Oct; 209(11):2017-31. PubMed ID: 23045605
[TBL] [Abstract][Full Text] [Related]
5. [Blocking PAK1 kinase activity promotes the differentiation of acute megakaryocytic leukemia cells and induces their apoptosis].
Wang SJ; Wang CQ; Hu XT; Yu XR; Fu CL
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):499-505. PubMed ID: 35968594
[No Abstract] [Full Text] [Related]
6. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition.
Wen QJ; Yang Q; Goldenson B; Malinge S; Lasho T; Schneider RK; Breyfogle LJ; Schultz R; Gilles L; Koppikar P; Abdel-Wahab O; Pardanani A; Stein B; Gurbuxani S; Mullally A; Levine RL; Tefferi A; Crispino JD
Nat Med; 2015 Dec; 21(12):1473-80. PubMed ID: 26569382
[TBL] [Abstract][Full Text] [Related]
7. Physical and functional interactions between mitotic kinases during polyploidization and megakaryocytic differentiation.
Huang X; Ruan Q; Fang Y; Traganos F; Darzynkiewicz Z; Dai W
Cell Cycle; 2004 Jul; 3(7):946-51. PubMed ID: 15190214
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of an AIM-1 kinase couples with megakaryocytic polyploidization of human hematopoietic cells.
Kawasaki A; Matsumura I; Miyagawa Ji ; Ezoe S; Tanaka H; Terada Y; Tatsuka M; Machii T; Miyazaki H; Furukawa Y; Kanakura Y
J Cell Biol; 2001 Jan; 152(2):275-87. PubMed ID: 11266445
[TBL] [Abstract][Full Text] [Related]
9. BMP2K dysregulation promotes abnormal megakaryopoiesis in acute megakaryoblastic leukemia.
Wang M; Zhang T; Zhang X; Jiang Z; Peng M; Huang Z
Cell Biosci; 2020; 10():57. PubMed ID: 32322386
[TBL] [Abstract][Full Text] [Related]
10. Functional reprogramming of polyploidization in megakaryocytes.
Trakala M; Rodríguez-Acebes S; Maroto M; Symonds CE; Santamaría D; Ortega S; Barbacid M; Méndez J; Malumbres M
Dev Cell; 2015 Jan; 32(2):155-67. PubMed ID: 25625205
[TBL] [Abstract][Full Text] [Related]
11. Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.
Mohan P; Castellsague J; Jiang J; Allen K; Chen H; Nemirovsky O; Spyra M; Hu K; Kluwe L; Pujana MA; Villanueva A; Mautner VF; Keats JJ; Dunn SE; Lazaro C; Maxwell CA
Oncotarget; 2013 Jan; 4(1):80-93. PubMed ID: 23328114
[TBL] [Abstract][Full Text] [Related]
12. Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression.
Zhang Y; Nagata Y; Yu G; Nguyen HG; Jones MR; Toselli P; Jackson CW; Tatsuka M; Todokoro K; Ravid K
Blood; 2004 May; 103(10):3717-26. PubMed ID: 14751927
[TBL] [Abstract][Full Text] [Related]
13. Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphoma.
Qi W; Cooke LS; Liu X; Rimsza L; Roe DJ; Manziolli A; Persky DO; Miller TP; Mahadevan D
Biochem Pharmacol; 2011 Apr; 81(7):881-90. PubMed ID: 21291867
[TBL] [Abstract][Full Text] [Related]
14. Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia.
Qi K; Hu X; Yu X; Cheng H; Wang C; Wang S; Wang Y; Li Y; Cao J; Pan B; Wu Q; Qiao J; Zeng L; Li Z; Xu K; Fu C
Leuk Res; 2022 Sep; 120():106920. PubMed ID: 35872339
[TBL] [Abstract][Full Text] [Related]
15. The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas.
Sehdev V; Katsha A; Ecsedy J; Zaika A; Belkhiri A; El-Rifai W
Cancer; 2013 Feb; 119(4):904-14. PubMed ID: 22972611
[TBL] [Abstract][Full Text] [Related]
16. Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism.
Kelly KR; Nawrocki ST; Espitia CM; Zhang M; Yang JJ; Padmanabhan S; Ecsedy J; Giles FJ; Carew JS
Int J Cancer; 2012 Dec; 131(11):2693-703. PubMed ID: 22488249
[TBL] [Abstract][Full Text] [Related]
17. Initial testing of the aurora kinase A inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP).
Maris JM; Morton CL; Gorlick R; Kolb EA; Lock R; Carol H; Keir ST; Reynolds CP; Kang MH; Wu J; Smith MA; Houghton PJ
Pediatr Blood Cancer; 2010 Jul; 55(1):26-34. PubMed ID: 20108338
[TBL] [Abstract][Full Text] [Related]
18. The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells.
Sehdev V; Peng D; Soutto M; Washington MK; Revetta F; Ecsedy J; Zaika A; Rau TT; Schneider-Stock R; Belkhiri A; El-Rifai W
Mol Cancer Ther; 2012 Mar; 11(3):763-74. PubMed ID: 22302096
[TBL] [Abstract][Full Text] [Related]
19. [SP600125-induced polyploidization of megakaryocytic leukemia cell lines by ribosomal protein S6 kinase 1 depends on the degree of cell differentiation].
Wang L; Yang J; Li C; Xing S; Yu Y; Liu S; Zhao S; Ma D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1336-1341. PubMed ID: 27667458
[TBL] [Abstract][Full Text] [Related]
20. Aurora kinase A is required for hematopoiesis but is dispensable for murine megakaryocyte endomitosis and differentiation.
Goldenson B; Kirsammer G; Stankiewicz MJ; Wen QJ; Crispino JD
Blood; 2015 Mar; 125(13):2141-50. PubMed ID: 25670627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
